Heartflow (HTFL) Cash from Operations (2024 - 2025)
Heartflow (HTFL) posted Cash from Operations of -$10.6 million for Q4 2025, down 258.34% on a QoQ basis from -$3.0 million in Q3 2025, and up 24.52% year-over-year from -$8.5 million in Q4 2024.
Powered by 
Analysis
Heartflow (HTFL) Cash from Operations (2024 - 2025) Analysis & Trends
Heartflow has reported Cash from Operations for 2 years, with the latest figure at -$10.6 million in Q4 2025.
- On a quarterly basis, Cash from Operations rose 24.52% year-over-year to -$10.6 million in Q4 2025; TTM through Dec 2025 was -$37.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$54.0 million, up 21.71% from the prior year.
- Cash from Operations was -$10.6 million for Q4 2025 at Heartflow, down from -$3.0 million in the prior quarter.
- The five-year high for Cash from Operations was -$3.0 million in Q3 2025, with the low at -$14.0 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 168.00 Mn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 92.20 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 30.20 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | -16.27 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | -110.60 Mn |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | -12.86 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 21.00 Mn |
| 10 | Prenetics Global | 357.49 Mn | 298.35 Mn | 30.20 Mn | -15.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -10.60 Mn |
| Sep 30, 2025 | -2.96 Mn |
| Dec 31, 2024 | -14.04 Mn |
| Sep 30, 2024 | -10.27 Mn |